Abstract
Late life depression is a prevalent disorder that affects elderly population. However, it is frequently sub diagnosed due to great variability in the sample involved, the definition of depression, the methodology used, and the experience of the evaluator.
Different subtypes of geriatric depression exist, each one with its own clinical characteristics. Depressive symptoms often are accompanied by cognitive impairment. Various diagnostic studies must be done to evaluate late life depression, such as depression scales, neuropsychological test, laboratory analyses and Neuroimages. As regards to treatment, antidepressants are always the first line option, especially IRSS due to its effectiveness and low rates of adverse events. Antipsychotics may provide benefit for agitated, psychotic, or resistant MDD in the elderly. Mood stabilizers are useful in bipolar depression such as lamotrigine, lithium and divalproate. This review aims to define the different subtypes of geriatric depression, describe diagnostic methods and revise recent data about pharmacological treatment.
Keywords: Clinical manifestations, diagnosis, late life depression, treatment.
Current Psychopharmacology
Title:Late Life Depression: A Diagnostic and Pharmacological Review
Volume: 3
Author(s): Carol Dillon, Clara Rodriguez and Fernando E. Taragano
Affiliation:
Keywords: Clinical manifestations, diagnosis, late life depression, treatment.
Abstract: Late life depression is a prevalent disorder that affects elderly population. However, it is frequently sub diagnosed due to great variability in the sample involved, the definition of depression, the methodology used, and the experience of the evaluator.
Different subtypes of geriatric depression exist, each one with its own clinical characteristics. Depressive symptoms often are accompanied by cognitive impairment. Various diagnostic studies must be done to evaluate late life depression, such as depression scales, neuropsychological test, laboratory analyses and Neuroimages. As regards to treatment, antidepressants are always the first line option, especially IRSS due to its effectiveness and low rates of adverse events. Antipsychotics may provide benefit for agitated, psychotic, or resistant MDD in the elderly. Mood stabilizers are useful in bipolar depression such as lamotrigine, lithium and divalproate. This review aims to define the different subtypes of geriatric depression, describe diagnostic methods and revise recent data about pharmacological treatment.
Export Options
About this article
Cite this article as:
Dillon Carol, Rodriguez Clara and Taragano E. Fernando, Late Life Depression: A Diagnostic and Pharmacological Review, Current Psychopharmacology 2014; 3 (1) . https://dx.doi.org/10.2174/2211556003666140702185640
DOI https://dx.doi.org/10.2174/2211556003666140702185640 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analgesic and Anti-Inflammatory Activities of Extracts and Fatty Acids from Celtis australis L
The Natural Products Journal Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitors in Combination with Angiotensin-Receptor Blockers in Nondiabetic Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Current Medicinal Chemistry Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews Diabetes-Induced Alterations in Renal Medullary Microcirculation and Metabolism
Current Diabetes Reviews Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy PREFACE: “The Lower the Better” Association between White-coat Effect-excluded Blood Pressure and Cardiovascular Events in High-risk Hypertension: Insights from SPRINT
Current Hypertension Reviews Melanocortins As Innovative Drugs for Ischemic Diseases and Neurodegenerative Disorders: Established Data and Perspectives
Current Medicinal Chemistry Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb
Current Medicinal Chemistry The Tumor Necrosis Factor-Derived TIP Peptide: A Potential Anti-Edema Drug
Letters in Drug Design & Discovery Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets The Complexity of Aging: Cancer Risk Among Elderly People and Infectious Risk Among Those with Cancer
Anti-Cancer Agents in Medicinal Chemistry Emerging Roles for Vasoactive Peptides in Diagnostic and Therapeutic Strategies Against Atherosclerotic Cardiovascular Diseases
Current Protein & Peptide Science L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure
Vascular Disease Prevention (Discontinued) Hypertension in Older Patients
Current Hypertension Reviews Plant based Coagulants for Point of Use Water Treatment – A Review
Current Environmental Engineering Beta-Blockers use for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Pharmacological Manipulation of Peripheral Vascular Resistance in Single Ventricle Patients (Stages I, II, and III of Palliation)
Current Vascular Pharmacology Herbal Medicine of the 21st Century: A Focus on the Chemistry, Pharmacokinetics and Toxicity of Five Widely Advocated Phytotherapies
Current Topics in Medicinal Chemistry